PetIQ Inc
NASDAQ:PETQ
Relative Value
The Relative Value of one PETQ stock under the Base Case scenario is 54.43 USD. Compared to the current market price of 17.58 USD, PetIQ Inc is Undervalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PETQ Competitors Multiples
PetIQ Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
PetIQ Inc
NASDAQ:PETQ
|
517.3m USD | 0.5 | 242.8 | 8.3 | 14.8 | ||
US |
Mckesson Corp
NYSE:MCK
|
71.5B USD | 0.2 | 23.8 | 16.5 | 19.2 | ||
US |
Cencora Inc
NYSE:COR
|
45.2B USD | 0.2 | 24.4 | 12 | 16.8 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.3B USD | 0.1 | 44.1 | 9 | 12 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD | 0.7 | 22.1 | 11.6 | 15.7 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
59.3B CNY | 1.5 | 21.9 | 16 | 16 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.6B EUR | 3.4 | 49.3 | 15.7 | 31.1 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
63.8B HKD | 0.1 | 6.6 | 1.6 | 1.9 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.5B CNY | 0.2 | 13.7 | 8.1 | 8.1 |